LINDA MING-HUEI LIAU, MD
Radiology in Los Angeles, CA
License number
California G76908
Category
Medical Practice
Type
Neurological Surgery
License number
California G76908
Category
Radiology
Type
Surgery
Address
Address
300 Medical Plz, Los Angeles, CA 90095
Phone
(310) 825-5111
Personal information
See more information about LINDA MING-HUEI LIAU at radaris.comName
Address
Phone
10418 Windtree Dr, Los Angeles, CA 90077
1160 Granville Ave APT 108, Los Angeles, CA 90049
1160 Granville Ave, Los Angeles, CA 90049
Professional information
Dr. Linda M Liau, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Neurosurgery
Address:
UCLA Neurosurgery Outpatnt Clnc
300 Ucla Medical Plz SUITE B200, Los Angeles 90095
(310) 794-1572 (Phone)
300 Ucla Medical Plz SUITE B200, Los Angeles 90095
(310) 794-1572 (Phone)
Certifications:
Neurosurgery, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UCLA Neurosurgery Outpatnt Clnc
300 Ucla Medical Plz SUITE B200, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
UCLA Medical Center, Santa Monica
1250 16Th St, Santa Monica 90404
300 Ucla Medical Plz SUITE B200, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
UCLA Medical Center, Santa Monica
1250 16Th St, Santa Monica 90404
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1991
UCLA Med Center
Graduated: 1992
Graduated: 1998
Graduated: 1999
Stanford University School Of Medicine
Graduated: 1991
UCLA Med Center
Graduated: 1992
Graduated: 1998
Graduated: 1999
Linda Ming-Huei Liau, Los Angeles CA
Specialties:
Neurosurgeon
Address:
300 Ucla Medical Plz, Los Angeles, CA 90095
Education:
Stanford University, School of Medicine - Doctor of Medicine
Ronald Reagan UCLA Medical Center - Fellowship - Neuro-Oncology
Ronald Reagan UCLA Medical Center - Residency - Neurological Surgery
Ronald Reagan UCLA Medical Center - Internship - Surgery
Ronald Reagan UCLA Medical Center - Fellowship - Neuro-Oncology
Ronald Reagan UCLA Medical Center - Residency - Neurological Surgery
Ronald Reagan UCLA Medical Center - Internship - Surgery
Board certifications:
American Board of Neurological Surgery Certification in Neurological Surgery
Linda Ming-Huei Liau, Los Angeles CA
Specialties:
Neurological Surgery, Surgery
Work:
UCLA/Neurosurgery
PO Box 951761, Los Angeles, CA 90095
PO Box 951761, Los Angeles, CA 90095
Education:
Stanford University (1991)
Methods For Detection And Treatment Of Neural Cancers
US Patent:
2002000, Jan 3, 2002
Filed:
Feb 28, 2001
Appl. No.:
09/795714
Inventors:
Linda Liau - Los Angeles CA, US
Assignee:
The Regents of the University of California
International Classification:
A61K048/00, A61K039/395
US Classification:
424/155100, 514/044000
Abstract:
The invention provides a method for inhibiting proliferation of neural cells. The neural cells can be tumor cells, glial cells, neuronal cells, and cells of the central or peripheral nervous systems. The method comprises contacting a neural cell with a molecule that disrupts the biological activity of a granulin molecule. In one embodiment, the molecule is an antibody directed against a granulin peptide. In other embodiments, the molecule is an antisense nucleotide directed against a granulin nucleic acid molecule, or a vaccine comprising a granulin peptide or a polynucleotide encoding a granulin peptide. The invention additionally provides methods for detecting and treating cancer in a neural tissue using granulin-related molecules. Also provided is a method for identifying differentially expressed gene products that are translated from mRNA species, using antibody-based screening of a cDNA expression library. This method, termed differential immuno-absorption (DIA), can be coupled to cDNA microarray hybridization and used in the identification of genes that play a role in the malignant progression of cancer.
Methods For Detection And Treatment Of Neural Cancers
US Patent:
7192704, Mar 20, 2007
Filed:
Mar 6, 2003
Appl. No.:
10/382945
Inventors:
Linda M. Liau - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 6, 436501, 436518, 435 71, 435 723
Abstract:
The invention provides a method for inhibiting proliferation of neural cells. The neural cells can be tumor cells, glial cells, neuronal cells, and cells of the central or peripheral nervous systems. The method comprises contacting a neural cell with a molecule that disrupts the biological activity of a granulin molecule. In one embodiment, the molecule is an antibody directed against a granulin peptide. In other embodiments, the molecule is an antisense nucleotide directed against a granulin nucleic acid molecule, or a vaccine comprising a granulin peptide or a polynucleotide encoding a granulin peptide. The invention additionally provides methods for detecting and treating cancer in a neural tissue using granulin-related molecules. Also provided is a method for indenting differentially expressed gene products that are translated from mRNA species, using antibody-based screening of a cDNA expression library. This method, termed differential immuno-absorption (DIA), can be coupled to cDNA microarray hybridization and used in the identification of genes that play a role in the malignant progression of cancer.
Compositions And Methods For Treatment And Detection Of Multiple Cancers
US Patent:
7204982, Apr 17, 2007
Filed:
Jul 2, 2002
Appl. No.:
10/188840
Inventors:
Linda M. Liau - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 39/395
US Classification:
4241301, 4241551, 4241851, 514 44, 536 231, 536 243
Abstract:
The invention provides a method for inhibiting proliferation of cancer cells, as well as methods for detecting and treating various cancers, including cancer of the brain, lung, breast, prostate and colon. The method comprises contacting a cancer cell with a molecule that disrupts the biological activity of a GDOX molecule. In one embodiment, the molecule is an antibody directed against a GDOX peptide. In other embodiments, the molecule is an antisense nucleotide directed against a GDOX nucleic acid molecule, or a vaccine comprising a GDOX peptide or a polynucleotide encoding a GDOX peptide. The invention additionally provides methods for detecting and treating cancer using GDOX-related molecules.